phosphoserine has been researched along with plx4032 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; de Polo, A; Gerarduzzi, C; Little, JB; Luo, Z; Yuan, ZM | 1 |
1 other study(ies) available for phosphoserine and plx4032
Article | Year |
---|---|
AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.
Topics: Axl Receptor Tyrosine Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cisplatin; Cyclin-Dependent Kinases; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Indoles; Melanoma; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Protein Stability; Protein Transport; Proteolysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sulfonamides; Transcription, Genetic; Tumor Suppressor Protein p53; Vemurafenib | 2017 |